Literature DB >> 28241891

Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.

T E Van Rheenen1, K E Lewandowski2, E J Tan3, L H Ospina4, D Ongur2, E Neill3, C Gurvich5, C Pantelis1, A K Malhotra6, S L Rossell3, K E Burdick4.   

Abstract

BACKGROUND: Current group-average analysis suggests quantitative but not qualitative cognitive differences between schizophrenia (SZ) and bipolar disorder (BD). There is increasing recognition that cognitive within-group heterogeneity exists in both disorders, but it remains unclear as to whether between-group comparisons of performance in cognitive subgroups emerging from within each of these nosological categories uphold group-average findings. We addressed this by identifying cognitive subgroups in large samples of SZ and BD patients independently, and comparing their cognitive profiles. The utility of a cross-diagnostic clustering approach to understanding cognitive heterogeneity in these patients was also explored.
METHOD: Hierarchical clustering analyses were conducted using cognitive data from 1541 participants (SZ n = 564, BD n = 402, healthy control n = 575).
RESULTS: Three qualitatively and quantitatively similar clusters emerged within each clinical group: a severely impaired cluster, a mild-moderately impaired cluster and a relatively intact cognitive cluster. A cross-diagnostic clustering solution also resulted in three subgroups and was superior in reducing cognitive heterogeneity compared with disorder clustering independently.
CONCLUSIONS: Quantitative SZ-BD cognitive differences commonly seen using group averages did not hold when cognitive heterogeneity was factored into our sample. Members of each corresponding subgroup, irrespective of diagnosis, might be manifesting the outcome of differences in shared cognitive risk factors.

Entities:  

Keywords:  Clustering; cognition; heterogeneity; neuropsychology; psychosis spectrum

Mesh:

Year:  2017        PMID: 28241891     DOI: 10.1017/S0033291717000307

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  39 in total

1.  Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk.

Authors:  Dag Alnæs; Tobias Kaufmann; Dennis van der Meer; Aldo Córdova-Palomera; Jaroslav Rokicki; Torgeir Moberget; Francesco Bettella; Ingrid Agartz; Deanna M Barch; Alessandro Bertolino; Christine L Brandt; Simon Cervenka; Srdjan Djurovic; Nhat Trung Doan; Sarah Eisenacher; Helena Fatouros-Bergman; Lena Flyckt; Annabella Di Giorgio; Beathe Haatveit; Erik G Jönsson; Peter Kirsch; Martina J Lund; Andreas Meyer-Lindenberg; Giulio Pergola; Emanuel Schwarz; Olav B Smeland; Tiziana Quarto; Mathias Zink; Ole A Andreassen; Lars T Westlye
Journal:  JAMA Psychiatry       Date:  2019-07-01       Impact factor: 21.596

2.  Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings.

Authors:  M Russo; T E Van Rheenen; M Shanahan; K Mahon; M M Perez-Rodriguez; A Cuesta-Diaz; E Larsen; A K Malhotra; K E Burdick
Journal:  Psychol Med       Date:  2017-06-07       Impact factor: 7.723

3.  Functional connectivity in distinct cognitive subtypes in psychosis.

Authors:  Kathryn E Lewandowski; Julie M McCarthy; Dost Öngür; Lesley A Norris; Geoffrey Z Liu; Richard J Juelich; Justin T Baker
Journal:  Schizophr Res       Date:  2018-08-17       Impact factor: 4.939

Review 4.  A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

Authors:  Camila Nascimento; Villela Paula Nunes; Roberta Diehl Rodriguez; Leonel Takada; Cláudia Kimie Suemoto; Lea Tenenholz Grinberg; Ricardo Nitrini; Beny Lafer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-04-20       Impact factor: 5.067

5.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

6.  Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis.

Authors:  Timothy Tanzer; Shelukumar Shah; Catherine Benson; Veronica De Monte; Victoria Gore-Jones; Susan L Rossell; Frances Dark; Steve Kisely; Dan Siskind; Catarina Drumonde Melo
Journal:  Psychopharmacology (Berl)       Date:  2019-12-03       Impact factor: 4.530

7.  Widespread Volumetric Reductions in Schizophrenia and Schizoaffective Patients Displaying Compromised Cognitive Abilities.

Authors:  Tamsyn E Van Rheenen; Vanessa Cropley; Andrew Zalesky; Chad Bousman; Ruth Wells; Jason Bruggemann; Suresh Sundram; Danielle Weinberg; Roshel K Lenroot; Avril Pereira; Cynthia Shannon Weickert; Thomas W Weickert; Christos Pantelis
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

8.  Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.

Authors:  Tamsyn E Van Rheenen; Kathryn E Lewandowski; Jessica M Lipschitz; Katherine E Burdick
Journal:  CNS Spectr       Date:  2018-09-24       Impact factor: 3.790

9.  Mapping cognitive trajectories across the course of illness in psychosis.

Authors:  Kathryn E Lewandowski
Journal:  Schizophr Res       Date:  2018-12-27       Impact factor: 4.939

10.  Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases.

Authors:  Alexander W Charney; Eli A Stahl; Elaine K Green; Chia-Yen Chen; Jennifer L Moran; Kimberly Chambert; Richard A Belliveau; Liz Forty; Katherine Gordon-Smith; Phil H Lee; Evelyn J Bromet; Peter F Buckley; Michael A Escamilla; Ayman H Fanous; Laura J Fochtmann; Douglas S Lehrer; Dolores Malaspina; Stephen R Marder; Christopher P Morley; Humberto Nicolini; Diana O Perkins; Jeffrey J Rakofsky; Mark H Rapaport; Helena Medeiros; Janet L Sobell; Lena Backlund; Sarah E Bergen; Anders Juréus; Martin Schalling; Paul Lichtenstein; James A Knowles; Katherine E Burdick; Ian Jones; Lisa A Jones; Christina M Hultman; Roy Perlis; Shaun M Purcell; Steven A McCarroll; Carlos N Pato; Michele T Pato; Ariana Di Florio; Nick Craddock; Mikael Landén; Jordan W Smoller; Douglas M Ruderfer; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2018-12-20       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.